PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,929,142 | +102.7% | 231,035 | +222.9% | 0.01% | +150.0% |
| Q2 2023 | $951,761 | +15.6% | 71,561 | +0.6% | 0.00% | 0.0% |
| Q1 2023 | $823,350 | +41.6% | 71,101 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $581,606 | +40.8% | 71,101 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $413,000 | +31.5% | 71,101 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $314,000 | -51.5% | 71,101 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $647,000 | -55.5% | 71,091 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $1,455,000 | -20.6% | 71,091 | -0.9% | 0.00% | -25.0% |
| Q3 2021 | $1,833,000 | -26.9% | 71,731 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $2,508,000 | +13.6% | 71,731 | +8.3% | 0.01% | +25.0% |
| Q1 2021 | $2,207,000 | +19.6% | 66,249 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $1,846,000 | +260.5% | 71,169 | +37.1% | 0.00% | +300.0% |
| Q3 2020 | $512,000 | +186.0% | 51,909 | 0.0% | 0.00% | – |
| Q2 2020 | $179,000 | +12.6% | 51,909 | 0.0% | 0.00% | – |
| Q1 2020 | $159,000 | -40.7% | 51,909 | -0.5% | 0.00% | -100.0% |
| Q4 2019 | $268,000 | -0.4% | 52,169 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $269,000 | -14.9% | 52,169 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $316,000 | -16.2% | 52,169 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $377,000 | -2.3% | 52,169 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $386,000 | +60.8% | 52,169 | +17.5% | 0.00% | 0.0% |
| Q3 2018 | $240,000 | +51.9% | 44,388 | 0.0% | 0.00% | – |
| Q2 2018 | $158,000 | +73.6% | 44,388 | 0.0% | 0.00% | – |
| Q1 2018 | $91,000 | -22.2% | 44,388 | 0.0% | 0.00% | – |
| Q4 2017 | $117,000 | -49.8% | 44,388 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $233,000 | +47.5% | 44,388 | 0.0% | 0.00% | – |
| Q2 2017 | $158,000 | -31.0% | 44,388 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $229,000 | +35.5% | 44,388 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $169,000 | -57.5% | 44,388 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $398,000 | +27.6% | 44,388 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $312,000 | +12.2% | 44,388 | +35.6% | 0.00% | 0.0% |
| Q1 2016 | $278,000 | -20.1% | 32,732 | +23.5% | 0.00% | 0.0% |
| Q4 2015 | $348,000 | +500.0% | 26,512 | +68.3% | 0.00% | – |
| Q3 2015 | $58,000 | -36.3% | 15,757 | 0.0% | 0.00% | – |
| Q2 2015 | $91,000 | -1.1% | 15,757 | 0.0% | 0.00% | – |
| Q1 2015 | $92,000 | -25.8% | 15,757 | 0.0% | 0.00% | – |
| Q4 2014 | $124,000 | +61.0% | 15,757 | 0.0% | 0.00% | – |
| Q3 2014 | $77,000 | -20.6% | 15,757 | 0.0% | 0.00% | – |
| Q2 2014 | $97,000 | – | 15,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |